✦ LIBER ✦

Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients

✍ Scribed by Saik Urien; Etienne Brain; Roland Bugat; Xavier Pivot; Isabelle Lochon; Marie-Louise Vo Van; Françoise Vauzelle; François Lokiec

Publisher: Springer
Year: 2004
Tongue: English
Weight: 364 KB
Volume: 55
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-004-0852-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacokinetics study of

A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors

✍ Josephia R. Muindi; Candace S. Johnson; Donald L. Trump; Renee Christy; Kristie 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 429 KB

Pilot study on the plasma pharmacokineti

Pilot study on the plasma pharmacokinetics of fumonisin B1 in cows following a single dose by oral gavage or intravenous administration

✍ Dr. Dan B. Prelusky; Marc E. Savard; H. Locksley Trenholm 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB

Phase 1b-2a study to reverse platinum re

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

✍ Siqing Fu; Wei Hu; Revathy Iyer; John J. Kavanagh; Robert L. Coleman; Charles F. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views

Role of salvage chemotherapy with topote

Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study

✍ Ghamande, Sharad A.; Piver, M. Steven 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

## Background and Objectives: We assessed the role of salvage chemotherapy with topotecan and cisplatin in patients with platinum-and paclitaxel-resistant advanced and recurrent ovarian or primary peritoneal cancer, based on the reported in vivo and in vitro synergism between these two drugs. Meth

A multicenter phase II study of combined

A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)

✍ Wasaburo Koizumi; Norisuke Nakayama; Satoshi Tanabe; Tohru Sasaki; Katsuhiko Hig 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 373 KB

MLN3897 plus methotrexate in patients wi

MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study

✍ Clarissa E. Vergunst; Danielle M. Gerlag; Lisa von Moltke; Michael Karol; Tim Wy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 3 views

## Abstract ## Objective To assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of the CC chemokine receptor CCR1 antagonist MLN3897 in patients with rheumatoid arthritis (RA) receiving methotrexate (MTX). ## Methods In this phase IIa, proof‐of‐concept study, patients meeting the